
News|Articles|October 1, 2001
Dalteparin for enoxaparin interchange: Chart review shows promising clinical, economic outcomes
University Hospital and Medical Center (Tamarac)/University of Florida (Gainesville)-Dalteparin appears to be at least as clinically effective as enoxaparin for the prevention or treatment of the consequences of venous and arterial thromboembolic diseases, say clinicians from these two facilities.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
A conversation about using GLP-1s to manage antipsychotic weight gain, with Mahavir Agarwal, M.D., Ph.D.
4
Ashley Holzworth-Nash, Pharm.D., Evernorth
5






















